SCHEMBL1111500

SCHEMBL1111500

CCCCCCCCCCCCCCCCOc1ccc(S(=O)(=O)Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.62
CA12 O43570 2/20 0.62
CA1 P00915 2/20 0.62
CA2 P00918 2/20 0.62
CA7 P43166 2/20 0.62
CA9 Q16790 2/20 0.62
NR5A1 Q13285 1/20 0.56
NPC1 O15118 2/20 0.55
RAB9A P51151 1/20 0.55
TP53 P04637 1/20 0.54
PLA2G4B P0C869 1/20 0.53
MAPK1 P28482 1/20 0.51
RECQL P46063 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
RARB P10826 3/20 0.50
LTA4H P09960 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10609795 1.00 TSHR (0.62) TSHRCA12CA1CA2CA7
SCHEMBL10600260 1.00 TSHR (0.62) TSHRCA12CA1CA2CA7
SCHEMBL7766693 1.00 TSHR (0.62) TSHRCA12CA1CA2CA7
SCHEMBL10606881 1.00 TSHR (0.62) TSHRCA12CA1CA2CA7
SCHEMBL10606406 1.00 TSHR (0.62) TSHRCA12CA1CA2CA7
SCHEMBL10608025 1.00 TSHR (0.62) TSHRCA12CA1CA2CA7
SCHEMBL10610971 1.00 TSHR (0.62) TSHRCA12CA1CA2CA7
SCHEMBL3369946 1.00 TSHR (0.62) TSHRCA12CA1CA2CA7
SCHEMBL10708683 1.00 TSHR (0.62) TSHRCA12CA1CA2CA7
SCHEMBL7280610 1.00 TSHR (0.62) TSHRCA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250302839-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF RIBOFLAVIN D&D Biopharmaceuticals, Inc. (US) 2025-10-02 US disclosed
US-20110086802-A1 METHODS TO INCREASE PERMEABILITY OF CORNEAL EPITHELIUM AND DESTABILIZE STROMAL COLLAGEN FIBRIL NETWORK EUCLID SYSTEMS CORPORATION 2011-04-14 US disclosed
EP-2278988-A2 METHODS TO INCREASE PERMEABILITY OF CORNEAL EPITHELIUM AND DESTABILIZE STROMAL COLLAGEN FIBRIL NETWORK Euclid Systems Corporation (US) 2011-02-02 EP disclosed
WO-2009120549-A2 METHODS TO INCREASE PERMEABILITY OF CORNEAL EPITHELIUM AND DESTABILIZE STROMAL COLLAGEN FIBRIL NETWORK EUCLID SYSTEMS CORPORATION (US) 2009-10-01 WO disclosed
EP-1051655-B1 METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY ISTA PHARMACEUTICALS INC (US) 2005-09-28 EP disclosed
EP-1051655-A4 METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY ISTA PHARMACEUTICALS INC (US) 2003-03-19 EP disclosed
US-20010016731-A1 Methods and apparatus for accelerated orthokeratology DEVORE DALE (US) 2001-08-23 US disclosed
US-6161544-A Methods for accelerated orthokeratology KERATOFORM, INC. (US) 2000-12-19 US disclosed
EP-1051655-A1 METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY Ista Pharmaceuticals, Inc. (US) 2000-11-15 EP disclosed
WO-1999039238-A1 METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY KERATOFORM, INC. (US) 1999-08-05 WO disclosed
EP-0471894-B1 Particulate toner material AGFA GEVAERT NV (BE) 1995-11-02 EP disclosed
US-5188919-A Imparting negative charge with sulfonylanthranilic acid derivatives; thermoplastic resins as binder; developing latent electrostatic images; xerography AGFA-GEVAERT, N.V. (BE) 1993-02-23 US disclosed
EP-0471894-A1 Particulate toner material AGFA-GEVAERT N.V. (BE) 1992-02-26 EP disclosed
US-4874894-A Process for the production of benzenesulfonamides HILTON DAVIS CO. (US) 1989-10-17 US disclosed